Status:
COMPLETED
Adherence With Iron Sprinkles Among High-Risk Infants
Lead Sponsor:
Centers for Disease Control and Prevention
Conditions:
Anemia
Iron Deficiency
Eligibility:
All Genders
5-7 years
Phase:
PHASE3
Brief Summary
Compared with iron drops, iron sprinkles supplied for 3 months to high-risk children beginning at age 5-7 months will increase adherence and reduce the rates of anemia and iron deficiency.
Detailed Description
Iron deficiency is the most common known nutrient deficiency and cause of anemia in childhood. It is associated with numerous adverse health effects, particularly delayed mental and motor development,...
Eligibility Criteria
Inclusion
- Healthy infants
- Age 5-7 months
- Presenting for 6 months well-child care
- Caregiver speaks English or Spanish
Exclusion
- Pre-existing medical conditions with potential relation to iron deficiency or anemia (e.g., hemoglobinopathies, gastrointestinal disorders resulting in malabsorption, chronic renal disease, gestational age at birth of less than 36 weeks, and HIV infection)
- Inability to speak English or Spanish
- Use of vitamin or iron supplements in the previous three months
Key Trial Info
Start Date :
March 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2005
Estimated Enrollment :
128 Patients enrolled
Trial Details
Trial ID
NCT00136266
Start Date
March 1 2005
End Date
December 1 2005
Last Update
February 3 2016
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Whittier Street Health Center
Boston, Massachusetts, United States, 02108
2
Boston Medical Center Pediatric Primary Care Clinic
Boston, Massachusetts, United States, 02118